Iron Dosing Calculator (Iron Deficit)
Calculates estimated elemental iron deficit using the Ganzoni equation and converts the result into practical IV iron treatment plans for common products including Venofer, Injectafer, Monoferric, Feraheme, and Ferrlecit.
Ganzoni equation
Total iron deficit (mg) = weight (kg) × [target Hb − current Hb] × 2.4 + iron stores
Default iron stores = 500 mg for adults. Ganzoni remains a commonly used method to estimate iron deficit, but final IV iron dosing should follow product-specific prescribing information. Ferritin and TSAT are optional interpretation fields and do not alter the Ganzoni dose calculation.
Estimated iron deficit
836 mg
Ganzoni estimate
Rounded treatment target
900 mg
Rounded to practical dosing
Hb gap
2.0 g/dL
Target − current Hb
Iron stores added
500 mg
Reservoir component
Estimated deficit fits within a typical 1,000 mg replacement course. Venofer at 200 mg per visit would require 5 visits.
Injectafer (ferric carboxymaltose)
Monoferric (ferric derisomaltose)
Feraheme (ferumoxytol)
Ferrlecit (sodium ferric gluconate)
Interpretation
Clinical summary
Reminder: IV iron products are not interchangeable milligram-for-milligram in terms of labeled administration schedules. This calculator estimates elemental iron need and then maps that estimate to common product-specific regimens.
References and dosing notes
Ganzoni equation
Iron sucrose
Ferric carboxymaltose
Ferric derisomaltose
Ferumoxytol
Ferric gluconate
- Ganzoni AM. Intravenous iron-dextran: therapeutic and experimental possibilities. Schweiz Med Wochenschr. 1970;100(7):301-303.
- Ganzoni equation: Total iron deficit (mg) = body weight (kg) × [target Hb − actual Hb in g/dL] × 2.4 + depot iron, commonly 500 mg in adults.
- Venofer prescribing information and Venofer dosing information.
- Injectafer prescribing information and Injectafer dosing information.
- Monoferric prescribing information.
- Feraheme prescribing information.
- Ferrlecit prescribing information.
This calculator is intended as a bedside planning tool and should be reconciled with the product label, infusion center protocol, and patient-specific contraindications.